Community Bank & Trust Waco Texas Has $389,000 Stake in Stryker Co. (NYSE:SYK)

Community Bank & Trust Waco Texas boosted its stake in Stryker Co. (NYSE:SYK) by 14.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,080 shares of the medical technology company’s stock after buying an additional 139 shares during the quarter. Community Bank & Trust Waco Texas’ holdings in Stryker were worth $389,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Dunhill Financial LLC raised its position in Stryker by 94.9% in the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock valued at $27,000 after buying an additional 37 shares during the last quarter. Darwin Wealth Management LLC purchased a new stake in Stryker in the 3rd quarter valued at $36,000. Activest Wealth Management bought a new position in Stryker in the 4th quarter valued at $36,000. Crews Bank & Trust bought a new position in Stryker in the 4th quarter valued at $39,000. Finally, Hara Capital LLC bought a new position in Stryker in the 3rd quarter valued at $42,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have issued reports on SYK shares. JPMorgan Chase & Co. upped their price objective on Stryker from $420.00 to $445.00 and gave the company an “overweight” rating in a research note on Wednesday, January 29th. Morgan Stanley upgraded Stryker from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $370.00 to $445.00 in a research note on Monday, December 2nd. JMP Securities reiterated a “market perform” rating on shares of Stryker in a research note on Tuesday, January 7th. Citigroup increased their price target on Stryker from $411.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $442.00 price target on shares of Stryker in a research note on Wednesday, January 29th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and an average price target of $420.68.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the transaction, the director now owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.90% of the stock is owned by company insiders.

Stryker Price Performance

Shares of SYK stock opened at $392.15 on Tuesday. The firm has a market cap of $149.50 billion, a P/E ratio of 50.53, a P/E/G ratio of 2.98 and a beta of 0.96. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The business’s 50 day moving average price is $377.23 and its 200-day moving average price is $365.14. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the firm earned $3.46 EPS. On average, equities research analysts anticipate that Stryker Co. will post 13.49 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s payout ratio is 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.